Novo Nordisk launches blockbuster diabetes drug Ozempic in India
- - Novo Nordisk launches blockbuster diabetes drug Ozempic in India
ReutersDecember 11, 2025 at 11:41 PM
0
FILE PHOTO: Pens for the diabetes drug Ozempic sit on a production line to be packaged at the Danish drugmaker Novo Nordisk's site in Hillerod, Denmark, September 26, 2023. REUTERS/Tom Little/File Photo
Dec 12 (Reuters) - Danish drugmaker Novo Nordisk launched its blockbuster diabetes drug Ozempic in India on Friday.
Ozempic, a once-weekly injectable approved by the U.S. Food and Drug Administration in 2017 for type 2 diabetes, has become a global bestseller and is widely used off-label for weight loss due to its appetite-suppressing effects.
(Reporting by Rishika Sadam and Kashish Tandon; Editing by Janane Venkatraman)
Source: “AOL Breaking”
